|
INTS4L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.772000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.224790E-03 |
| Normal-vs-Stage2 |
6.438900E-03 |
| Normal-vs-Stage3 |
1.063690E-02 |
| Normal-vs-Stage4 |
5.895400E-03 |
| Stage1-vs-Stage2 |
6.867000E-01 |
| Stage1-vs-Stage3 |
7.467800E-01 |
| Stage1-vs-Stage4 |
6.013600E-01 |
| Stage2-vs-Stage3 |
5.564200E-01 |
| Stage2-vs-Stage4 |
9.246000E-01 |
| Stage3-vs-Stage4 |
4.895800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.635100E-03 |
| Normal-vs-AfricanAmerican |
5.597700E-02 |
| Normal-vs-Asian |
3.634400E-02 |
| Caucasian-vs-AfricanAmerican |
7.401400E-01 |
| Caucasian-vs-Asian |
9.521600E-01 |
| AfricanAmerican-vs-Asian |
8.123800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.962200E-04 |
| Normal-vs-Female |
7.538800E-03 |
| Male-vs-Female |
1.828620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.799500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.759000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.337710E-02 |
| Normal-vs-Age(81-100Yrs) |
2.245600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.060600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.970400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.573600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.741800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.116600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.249200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.047800E-01 |
| Classical-VS-Follicular |
2.017500E-02 |
| Classical-VS-Other |
3.617600E-01 |
| Classical-VS-Normal |
8.337700E-03 |
| Tall-VS-Follicular |
9.541800E-01 |
| Tall-VS-Other |
8.252200E-01 |
| Tall-VS-Normal |
1.256030E-02 |
| Follicular-VS-Other |
8.012000E-01 |
| Follicular-VS-Normal |
6.842900E-04 |
| Other-VS-Normal |
1.049200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.841400E-03 |
| Normal-vs-N1 |
2.294300E-02 |
| N0-vs-N1 |
8.040000E-01 |
|
|
